Inflammatory indices-Systemic Immune- Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI)-during Pregnancy and Associations with Gestational Diabetes Mellitus

被引:2
|
作者
Zhang, Danwei [1 ]
Zeng, Yating [1 ]
Sun, Bin [2 ]
Li, Wei [2 ]
Liu, Wenjuan [2 ]
Gao, Haiyan [2 ]
Zhu, Yibing [2 ]
Li, Haibo [2 ]
Chen, Qiang [1 ]
机构
[1] Fujian Med Univ, Fujian Childrens Hosp, Coll Clin Med Obstet & Gynecol & Pediat, Fujian Branch,Shanghai Childrens Med Ctr,Dept Car, 66 Hengyu Rd, Fuzhou 350014, Peoples R China
[2] Fujian Med Univ, Fujian Matern & Child Hlth Hosp, Coll Clin Med Obstet & Gynecol & Pediat, Div Birth Cohort Study, 18 Daoshan Rd, Fuzhou 350001, Peoples R China
关键词
gestational diabetes mellitus; GDM; systemic immune-inflammation index; SII; systemic inflammatory response index; SIRI; PREDICTION; BIOMARKERS; PLATELETS;
D O I
10.2147/JIR.S474154
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: Gestational diabetes mellitus (GDM) is a prevalent complication during pregnancy. This study aimed to explore the associations between inflammatory indices during pregnancy and the development of GDM. Methods: Data from the Fujian Birth Cohort Study between March 2019 and December 2022 were used. Participants who delivered a live-born singleton were included and categorized into GDM and non-GDM groups. Two inflammatory indices, the systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI), were calculated for each trimester of pregnancy via hematological parameters from complete blood count tests. The distributions of inflammatory indicators across trimesters were compared between the GDM and non-GDM groups. Additionally, multivariable logistic regression models were employed to investigate the associations between inflammatory indices and the incidence of GDM. Results: A total of 17297 participants were included, 21.2% of whom were diagnosed with GDM. In the first trimester, the median SIIs for the GDM and non-GDM groups were 817.7x10(9)/L 9 /L and 756.9x10(9)/L, 9 /L, respectively, whereas the median SIRIs were 1.6x10(9)/L 9 /L and 1.5x10(9)/L, 9 /L, respectively. In both groups, the SII increased to its peak in the second trimester before declining, whereas the SIRI progressively increased throughout pregnancy. The SII and SIRI were greater in the GDM group than in the non-GDM group during the first two trimesters but lower in the third trimester. Nonlinear positive associations between first-trimester SII and SIRI levels and GDM were observed, with extreme quartile odds ratios of 1.32 (95% CI: 1.19, 1.48) and 1.39 (95% CI: 1.24, 1.55), respectively. Conclusion: The SII and SIRI increased and reached their peak values in the second and third trimesters of pregnancy, respectively. Elevated levels of the SII and SIRI in early pregnancy were linked to an increased risk of GDM, suggesting their potential utility as screening tools for GDM.
引用
收藏
页码:6521 / 6532
页数:12
相关论文
共 50 条
  • [21] Correlations Between Acute Coronary Syndrome and Novel Inflammatory Markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Aggregate Index of Systemic Inflammation) in Patients with and without Diabetes or Prediabetes
    Tuzimek, Agnieszka
    Dziedzic, Ewelina A.
    Beck, Joanna
    Kochman, Waclaw
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 2623 - 2632
  • [22] Effect of Treatment With Biologic Agents on the Novel Inflammatory Biomarkers Systemic Immune Inflammation Index and Systemic Inflammation Response Index for Psoriasis
    Tamer, Funda
    Edek, Yusuf Can
    Aksakal, Ahmet Burhan
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (01):
  • [23] Association of systemic immune-inflammation index (SII) and aggregate index of systemic inflammation (AISI) with thyroid nodules in patients with type 2 diabetes mellitus: a retrospective study
    Can Cao
    Chunyao Li
    Xiaoting Li
    Weiwei Sun
    Yaoxian Wang
    BMC Endocrine Disorders, 23
  • [24] Association of systemic immune-inflammation index (SII) and aggregate index of systemic inflammation (AISI) with thyroid nodules in patients with type 2 diabetes mellitus: a retrospective study
    Cao, Can
    Li, Chunyao
    Li, Xiaoting
    Sun, Weiwei
    Wang, Yaoxian
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [25] Systemic Inflammation Response Index and Systemic Immune-inflammation Index for Prediction of Pregnancy Loss: a Case-control Study
    Agaoglu, Zahid
    Tanacan, Atakan
    Ipek, Goksun
    Peker, Ayca
    Ozturk Agaoglu, Merve
    Sahin, Dilek
    REPRODUCTIVE SCIENCES, 2024, 31 (06) : 1565 - 1572
  • [26] The role of first-trimester NLR (neutrophil to lymphocyte ratio), systemic immune-inflammation index (SII), and, systemic immune-response index (SIRI) in the prediction of composite adverse outcomes in pregnant women with systemic lupus erythematosus
    Sahin, Refaettin
    Tanacan, Atakan
    Serbetci, Hakki
    Agaoglu, Zahid
    Karagoz, Busra
    Haksever, Murat
    Kara, Ozgur
    Sahin, Dilek
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2023, 158
  • [27] Association of Systemic Immune-Inflammation Index and Systemic Inflammation Response Index with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Liu, Wenli
    Zheng, Shuran
    Du, Xiaogang
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 517 - 531
  • [28] Relationship between the clinical outcomes and the systemic inflammatory response index and systemic immune inflammation index after total knee arthroplasty
    Kürüm H.
    Key S.
    Tosun H.B.
    Yılmaz E.
    Kürüm K.O.
    İpekten F.
    Akcan A.
    MUSCULOSKELETAL SURGERY, 2024, 108 (3) : 323 - 332
  • [29] The Importance of Systemic Inflammatory Response Index, Systemic Immune-Inflammation Index, and Hemoglobin-Albumin-Lymphocytes-Platelets (HALP) Score in Children With Cancer
    Ertan, Kubra
    Kara, Buket
    Disci, Sekibe Isik
    Vatansev, Husamettin
    Koksal, Yavuz
    IRANIAN JOURNAL OF PEDIATRICS, 2021, 31 (06)
  • [30] Role of Systemic Immune Inflammatory Index to Predict Intrahepatic Cholestasis of Pregnancy
    Ergani, Seval Y.
    Celen, Sevki
    CLINICAL LABORATORY, 2024, 70 (03) : 555 - 561